Trademark search for:

CEBITROPIN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2022-02-17 — Application filed
2022-02-21 — Application filed
2022-02-22 — Application filed
2022-12-02 — Assigned to examiner
2022-12-05 — Examiners amendment -written
2022-12-05 — Examiners amendment e-mailed
2022-12-05 — Notification of examiners amendment e-mailed
2022-12-05 — Examiner's amendment entered
2022-12-06 — Approved for pub - principal register
2022-12-21 — Notification of notice of publication e-mailed
2023-01-10 — Published for opposition
2023-01-10 — Official gazette publication confirmation e-mailed
2023-03-07 — Noa e-mailed - sou required from applicant
2023-04-03 — Attorney/dom.rep.revoked and/or appointed
2023-04-03 — Teas change of correspondence received
2023-04-03 — Teas withdrawal of attorney received
2023-04-03 — Teas revoke/app/change addr of atty/dom rep received
2023-04-03 — Withdrawal of attorney granted
2023-10-09 — Application abandoned
2023-10-09 — Final status recorded
2023-10-10 — Application abandoned

Owner Information

Centro de Biotecnologia y Biomedicina SpA
Concepcion CL

Correspondent

Mike Rodenbaugh Rodenbaugh Law
548 Market St, Box 55819
San Francisco, CA 94104
UNITED STATES

Filing Details

Filing Date:
2022-02-17

Status Date:
2023-10-09

Category:
Pharmaceuticals

Filing Year:
2022

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.